APO Research
Talk to an analyst

APO RESEARCH · REPORT

Loratadine API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Loratadine API Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchLoratadine API Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Loratadine API Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Loratadine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Loratadine API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Loratadine API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Loratadine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Loratadine API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Loratadine API market include Shenzhen Salubris Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Merck Group, Mylan, Shaanxi Hanjiang, Changzhou Yabang, Changzhou Fangyuan Pharmaceutical, Vasudha Pharma Chem and Ultratech India Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Loratadine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Loratadine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Loratadine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Loratadine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Loratadine API Segment by Company

Shenzhen Salubris Pharmaceuticals

Shenzhen Haibin Pharmaceutical

Merck Group

Mylan

Shaanxi Hanjiang

Changzhou Yabang

Changzhou Fangyuan Pharmaceutical

Vasudha Pharma Chem

Ultratech India Limited

Morepen

Inke, S.A.

Hetero Drugs Ltd

Cadila Pharmaceuticals

Argon Drugs

Loratadine API Segment by Type

Pharmaceutical Standards Grade

EP Standards Grade

USP Standards Grade

Others

Loratadine API Segment by Application

Loratadine Syrup

Loratadine Tablet

Loratadine Capsules

Dry Suspension

Others

Loratadine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Loratadine API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Loratadine API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Loratadine API significant trends, drivers, influence factors in global and regions.

6. To analyze Loratadine API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loratadine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Loratadine API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Loratadine API industry.

Chapter 3: Detailed analysis of Loratadine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Loratadine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Loratadine API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Loratadine API Industry Trends Table 2. Loratadine API Industry Drivers Table 3. Loratadine API Industry Opportunities and Challenges Table 4. Loratadine API Industry Restraints Table 5. Global Loratadine API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Loratadine API Revenue Share by Company (2021-2026) Table 7. Global Loratadine API Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Loratadine API Sales Volume Share by Company (2021-2026) Table 9. Global Loratadine API Average Price (US$/ton) of Company (2021-2026) Table 10. Global Loratadine API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Loratadine API Key Company Manufacturing Base & Headquarters Table 12. Global Loratadine API Company, Product Type & Application Table 13. Global Loratadine API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Loratadine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pharmaceutical Standards Grade Table 18. Significant Companies of EP Standards Grade Table 19. Significant Companies of USP Standards Grade Table 20. Significant Companies of Others Table 21. Global Loratadine API Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 22. Global Loratadine API Sales Volume by Type (2021-2026) & (k tons) Table 23. Global Loratadine API Sales Volume by Type (2027-2032) & (k tons) Table 24. Global Loratadine API Sales Volume Share by Type (2021-2026) Table 25. Global Loratadine API Sales Volume Share by Type (2027-2032) Table 26. Global Loratadine API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Loratadine API Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Loratadine API Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Loratadine API Sales Value Share by Type (2021-2026) Table 30. Global Loratadine API Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Loratadine Syrup Table 32. Significant Companies of Loratadine Tablet Table 33. Significant Companies of Loratadine Capsules Table 34. Significant Companies of Dry Suspension Table 35. Significant Companies of Others Table 36. Global Loratadine API Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 37. Global Loratadine API Sales Volume by Application (2021-2026) & (k tons) Table 38. Global Loratadine API Sales Volume by Application (2027-2032) & (k tons) Table 39. Global Loratadine API Sales Volume Share by Application (2021-2026) Table 40. Global Loratadine API Sales Volume Share by Application (2027-2032) Table 41. Global Loratadine API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Loratadine API Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Loratadine API Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Loratadine API Sales Value Share by Application (2021-2026) Table 45. Global Loratadine API Sales Value Share by Application (2027-2032) Table 46. Global Loratadine API Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 47. Global Loratadine API Sales by Region (2021-2026) & (k tons) Table 48. Global Loratadine API Sales Market Share by Region (2021-2026) Table 49. Global Loratadine API Sales by Region (2027-2032) & (k tons) Table 50. Global Loratadine API Sales Market Share by Region (2027-2032) Table 51. Global Loratadine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Loratadine API Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Loratadine API Sales Value Share by Region (2021-2026) Table 54. Global Loratadine API Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Loratadine API Sales Value Share by Region (2027-2032) Table 56. Global Loratadine API Market Average Price (US$/ton) by Region (2021-2026) Table 57. Global Loratadine API Market Average Price (US$/ton) by Region (2027-2032) Table 58. Global Loratadine API Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 59. Global Loratadine API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Loratadine API Sales by Country (2021-2026) & (k tons) Table 61. Global Loratadine API Sales Market Share by Country (2021-2026) Table 62. Global Loratadine API Sales by Country (2027-2032) & (k tons) Table 63. Global Loratadine API Sales Market Share by Country (2027-2032) Table 64. Global Loratadine API Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Loratadine API Sales Value Market Share by Country (2021-2026) Table 66. Global Loratadine API Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Loratadine API Sales Value Market Share by Country (2027-2032) Table 68. Shenzhen Salubris Pharmaceuticals Company Information Table 69. Shenzhen Salubris Pharmaceuticals Business Overview Table 70. Shenzhen Salubris Pharmaceuticals Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio Table 72. Shenzhen Salubris Pharmaceuticals Recent Development Table 73. Shenzhen Haibin Pharmaceutical Company Information Table 74. Shenzhen Haibin Pharmaceutical Business Overview Table 75. Shenzhen Haibin Pharmaceutical Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio Table 77. Shenzhen Haibin Pharmaceutical Recent Development Table 78. Merck Group Company Information Table 79. Merck Group Business Overview Table 80. Merck Group Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Merck Group Loratadine API Product Portfolio Table 82. Merck Group Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Mylan Loratadine API Product Portfolio Table 87. Mylan Recent Development Table 88. Shaanxi Hanjiang Company Information Table 89. Shaanxi Hanjiang Business Overview Table 90. Shaanxi Hanjiang Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Shaanxi Hanjiang Loratadine API Product Portfolio Table 92. Shaanxi Hanjiang Recent Development Table 93. Changzhou Yabang Company Information Table 94. Changzhou Yabang Business Overview Table 95. Changzhou Yabang Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Changzhou Yabang Loratadine API Product Portfolio Table 97. Changzhou Yabang Recent Development Table 98. Changzhou Fangyuan Pharmaceutical Company Information Table 99. Changzhou Fangyuan Pharmaceutical Business Overview Table 100. Changzhou Fangyuan Pharmaceutical Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio Table 102. Changzhou Fangyuan Pharmaceutical Recent Development Table 103. Vasudha Pharma Chem Company Information Table 104. Vasudha Pharma Chem Business Overview Table 105. Vasudha Pharma Chem Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Vasudha Pharma Chem Loratadine API Product Portfolio Table 107. Vasudha Pharma Chem Recent Development Table 108. Ultratech India Limited Company Information Table 109. Ultratech India Limited Business Overview Table 110. Ultratech India Limited Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Ultratech India Limited Loratadine API Product Portfolio Table 112. Ultratech India Limited Recent Development Table 113. Morepen Company Information Table 114. Morepen Business Overview Table 115. Morepen Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. Morepen Loratadine API Product Portfolio Table 117. Morepen Recent Development Table 118. Inke, S.A. Company Information Table 119. Inke, S.A. Business Overview Table 120. Inke, S.A. Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 121. Inke, S.A. Loratadine API Product Portfolio Table 122. Inke, S.A. Recent Development Table 123. Hetero Drugs Ltd Company Information Table 124. Hetero Drugs Ltd Business Overview Table 125. Hetero Drugs Ltd Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 126. Hetero Drugs Ltd Loratadine API Product Portfolio Table 127. Hetero Drugs Ltd Recent Development Table 128. Cadila Pharmaceuticals Company Information Table 129. Cadila Pharmaceuticals Business Overview Table 130. Cadila Pharmaceuticals Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 131. Cadila Pharmaceuticals Loratadine API Product Portfolio Table 132. Cadila Pharmaceuticals Recent Development Table 133. Argon Drugs Company Information Table 134. Argon Drugs Business Overview Table 135. Argon Drugs Loratadine API Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 136. Argon Drugs Loratadine API Product Portfolio Table 137. Argon Drugs Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Loratadine API Distributors List Table 141. Loratadine API Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Loratadine API Product Image Figure 2. Global Loratadine API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loratadine API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Loratadine API Sales (2021-2032) & (k tons) Figure 5. Global Loratadine API Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Loratadine API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pharmaceutical Standards Grade Image Figure 10. EP Standards Grade Image Figure 11. USP Standards Grade Image Figure 12. Others Image Figure 13. Global Loratadine API Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Loratadine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Loratadine API Sales Volume Share by Type (2021-2032) Figure 16. Global Loratadine API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Loratadine API Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Loratadine API Sales Value Share by Type (2021-2032) Figure 19. Loratadine Syrup Image Figure 20. Loratadine Tablet Image Figure 21. Loratadine Capsules Image Figure 22. Dry Suspension Image Figure 23. Others Image Figure 24. Global Loratadine API Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 25. Global Loratadine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Loratadine API Sales Volume Share by Application (2021-2032) Figure 27. Global Loratadine API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Loratadine API Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Loratadine API Sales Value Share by Application (2021-2032) Figure 30. Global Loratadine API Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 31. Global Loratadine API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Loratadine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Loratadine API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Loratadine API Sales Value (2021-2032) & (US$ Million) Figure 35. North America Loratadine API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Loratadine API Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Loratadine API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Loratadine API Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Loratadine API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Loratadine API Sales Value (2021-2032) & (US$ Million) Figure 41. South America Loratadine API Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Loratadine API Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Loratadine API Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Loratadine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Loratadine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Loratadine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Loratadine API Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Loratadine API Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Standards Grade
  • EP Standards Grade
  • USP Standards Grade
  • Others
Applications
  • Loratadine Syrup
  • Loratadine Tablet
  • Loratadine Capsules
  • Dry Suspension
  • Others
Companies covered
  • Shenzhen Salubris Pharmaceuticals
  • Shenzhen Haibin Pharmaceutical
  • Merck Group
  • Mylan
  • Shaanxi Hanjiang
  • Changzhou Yabang
  • Changzhou Fangyuan Pharmaceutical
  • Vasudha Pharma Chem
  • Ultratech India Limited
  • Morepen
  • Inke, S.A.
  • Hetero Drugs Ltd
  • Cadila Pharmaceuticals
  • Argon Drugs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Loratadine API Sales Value (2021-2032)
  4. 1.2.2 Global Loratadine API Sales Volume (2021-2032)
  5. 1.2.3 Global Loratadine API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Loratadine API Market Dynamics
  1. 2.1 Loratadine API Industry Trends
  2. 2.2 Loratadine API Industry Drivers
  3. 2.3 Loratadine API Industry Opportunities and Challenges
  4. 2.4 Loratadine API Industry Restraints
3 Loratadine API Market by Company
  1. 3.1 Global Loratadine API Company Revenue Ranking in 2025
  2. 3.2 Global Loratadine API Revenue by Company (2021-2026)
  3. 3.3 Global Loratadine API Sales Volume by Company (2021-2026)
  4. 3.4 Global Loratadine API Average Price by Company (2021-2026)
  5. 3.5 Global Loratadine API Company Ranking (2024-2026)
  6. 3.6 Global Loratadine API Company Manufacturing Base and Headquarters
  7. 3.7 Global Loratadine API Company Product Type and Application
  8. 3.8 Global Loratadine API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Loratadine API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Loratadine API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Loratadine API Market by Type
  1. 4.1 Loratadine API Type Introduction
  2. 4.1.1 Pharmaceutical Standards Grade
  3. 4.1.2 EP Standards Grade
  4. 4.1.3 USP Standards Grade
  5. 4.1.4 Others
  6. 4.2 Global Loratadine API Sales Volume by Type
  7. 4.2.1 Global Loratadine API Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Loratadine API Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Loratadine API Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Loratadine API Sales Value by Type
  11. 4.3.1 Global Loratadine API Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Loratadine API Sales Value by Type (2021-2032)
  13. 4.3.3 Global Loratadine API Sales Value Share by Type (2021-2032)
5 Loratadine API Market by Application
  1. 5.1 Loratadine API Application Introduction
  2. 5.1.1 Loratadine Syrup
  3. 5.1.2 Loratadine Tablet
  4. 5.1.3 Loratadine Capsules
  5. 5.1.4 Dry Suspension
  6. 5.1.5 Others
  7. 5.2 Global Loratadine API Sales Volume by Application
  8. 5.2.1 Global Loratadine API Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Loratadine API Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Loratadine API Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Loratadine API Sales Value by Application
  12. 5.3.1 Global Loratadine API Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Loratadine API Sales Value by Application (2021-2032)
  14. 5.3.3 Global Loratadine API Sales Value Share by Application (2021-2032)
6 Loratadine API Regional Sales and Value Analysis
  1. 6.1 Global Loratadine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Loratadine API Sales by Region (2021-2032)
  3. 6.2.1 Global Loratadine API Sales by Region: 2021-2026
  4. 6.2.2 Global Loratadine API Sales by Region (2027-2032)
  5. 6.3 Global Loratadine API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Loratadine API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Loratadine API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Loratadine API Sales Value by Region (2027-2032)
  9. 6.5 Global Loratadine API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Loratadine API Sales Value (2021-2032)
  12. 6.6.2 North America Loratadine API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Loratadine API Sales Value (2021-2032)
  15. 6.7.2 Europe Loratadine API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Loratadine API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Loratadine API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Loratadine API Sales Value (2021-2032)
  21. 6.9.2 South America Loratadine API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Loratadine API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Loratadine API Sales Value Share by Country, 2025 VS 2032
7 Loratadine API Country-level Sales and Value Analysis
  1. 7.1 Global Loratadine API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Loratadine API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Loratadine API Sales by Country (2021-2032)
  4. 7.3.1 Global Loratadine API Sales by Country (2021-2026)
  5. 7.3.2 Global Loratadine API Sales by Country (2027-2032)
  6. 7.4 Global Loratadine API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Loratadine API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Loratadine API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Loratadine API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Loratadine API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Loratadine API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Loratadine API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Loratadine API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Loratadine API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Loratadine API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Loratadine API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Loratadine API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Loratadine API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Loratadine API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Loratadine API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Loratadine API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Loratadine API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Loratadine API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Loratadine API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Loratadine API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Loratadine API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Loratadine API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Loratadine API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Loratadine API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Loratadine API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Loratadine API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Loratadine API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Loratadine API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Loratadine API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Loratadine API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Loratadine API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Loratadine API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Loratadine API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Loratadine API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Loratadine API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Loratadine API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Loratadine API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Loratadine API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Loratadine API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Loratadine API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Loratadine API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Loratadine API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Loratadine API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Loratadine API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Loratadine API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Loratadine API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Loratadine API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Loratadine API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Loratadine API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Loratadine API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Loratadine API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Loratadine API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Loratadine API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Loratadine API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Loratadine API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Loratadine API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Loratadine API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Loratadine API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Loratadine API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Loratadine API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Loratadine API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Loratadine API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Loratadine API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Loratadine API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Loratadine API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Loratadine API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Loratadine API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Loratadine API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Loratadine API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Loratadine API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Loratadine API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Loratadine API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Loratadine API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Loratadine API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Loratadine API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Loratadine API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Loratadine API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Loratadine API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Loratadine API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Loratadine API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Loratadine API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Loratadine API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Loratadine API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Loratadine API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Loratadine API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Loratadine API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Loratadine API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen Salubris Pharmaceuticals
  2. 8.1.1 Shenzhen Salubris Pharmaceuticals Company Information
  3. 8.1.2 Shenzhen Salubris Pharmaceuticals Business Overview
  4. 8.1.3 Shenzhen Salubris Pharmaceuticals Loratadine API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio
  6. 8.1.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  7. 8.2 Shenzhen Haibin Pharmaceutical
  8. 8.2.1 Shenzhen Haibin Pharmaceutical Company Information
  9. 8.2.2 Shenzhen Haibin Pharmaceutical Business Overview
  10. 8.2.3 Shenzhen Haibin Pharmaceutical Loratadine API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio
  12. 8.2.5 Shenzhen Haibin Pharmaceutical Recent Developments
  13. 8.3 Merck Group
  14. 8.3.1 Merck Group Company Information
  15. 8.3.2 Merck Group Business Overview
  16. 8.3.3 Merck Group Loratadine API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Group Loratadine API Product Portfolio
  18. 8.3.5 Merck Group Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Loratadine API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Loratadine API Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Shaanxi Hanjiang
  26. 8.5.1 Shaanxi Hanjiang Company Information
  27. 8.5.2 Shaanxi Hanjiang Business Overview
  28. 8.5.3 Shaanxi Hanjiang Loratadine API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shaanxi Hanjiang Loratadine API Product Portfolio
  30. 8.5.5 Shaanxi Hanjiang Recent Developments
  31. 8.6 Changzhou Yabang
  32. 8.6.1 Changzhou Yabang Company Information
  33. 8.6.2 Changzhou Yabang Business Overview
  34. 8.6.3 Changzhou Yabang Loratadine API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Changzhou Yabang Loratadine API Product Portfolio
  36. 8.6.5 Changzhou Yabang Recent Developments
  37. 8.7 Changzhou Fangyuan Pharmaceutical
  38. 8.7.1 Changzhou Fangyuan Pharmaceutical Company Information
  39. 8.7.2 Changzhou Fangyuan Pharmaceutical Business Overview
  40. 8.7.3 Changzhou Fangyuan Pharmaceutical Loratadine API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio
  42. 8.7.5 Changzhou Fangyuan Pharmaceutical Recent Developments
  43. 8.8 Vasudha Pharma Chem
  44. 8.8.1 Vasudha Pharma Chem Company Information
  45. 8.8.2 Vasudha Pharma Chem Business Overview
  46. 8.8.3 Vasudha Pharma Chem Loratadine API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Vasudha Pharma Chem Loratadine API Product Portfolio
  48. 8.8.5 Vasudha Pharma Chem Recent Developments
  49. 8.9 Ultratech India Limited
  50. 8.9.1 Ultratech India Limited Company Information
  51. 8.9.2 Ultratech India Limited Business Overview
  52. 8.9.3 Ultratech India Limited Loratadine API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ultratech India Limited Loratadine API Product Portfolio
  54. 8.9.5 Ultratech India Limited Recent Developments
  55. 8.10 Morepen
  56. 8.10.1 Morepen Company Information
  57. 8.10.2 Morepen Business Overview
  58. 8.10.3 Morepen Loratadine API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Morepen Loratadine API Product Portfolio
  60. 8.10.5 Morepen Recent Developments
  61. 8.11 Inke, S.A.
  62. 8.11.1 Inke, S.A. Company Information
  63. 8.11.2 Inke, S.A. Business Overview
  64. 8.11.3 Inke, S.A. Loratadine API Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Inke, S.A. Loratadine API Product Portfolio
  66. 8.11.5 Inke, S.A. Recent Developments
  67. 8.12 Hetero Drugs Ltd
  68. 8.12.1 Hetero Drugs Ltd Company Information
  69. 8.12.2 Hetero Drugs Ltd Business Overview
  70. 8.12.3 Hetero Drugs Ltd Loratadine API Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hetero Drugs Ltd Loratadine API Product Portfolio
  72. 8.12.5 Hetero Drugs Ltd Recent Developments
  73. 8.13 Cadila Pharmaceuticals
  74. 8.13.1 Cadila Pharmaceuticals Company Information
  75. 8.13.2 Cadila Pharmaceuticals Business Overview
  76. 8.13.3 Cadila Pharmaceuticals Loratadine API Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Cadila Pharmaceuticals Loratadine API Product Portfolio
  78. 8.13.5 Cadila Pharmaceuticals Recent Developments
  79. 8.14 Argon Drugs
  80. 8.14.1 Argon Drugs Company Information
  81. 8.14.2 Argon Drugs Business Overview
  82. 8.14.3 Argon Drugs Loratadine API Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Argon Drugs Loratadine API Product Portfolio
  84. 8.14.5 Argon Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Loratadine API Value Chain Analysis
  2. 9.1.1 Loratadine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Loratadine API Sales Mode & Process
  6. 9.2 Loratadine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Loratadine API Distributors
  9. 9.2.3 Loratadine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst